ArticleNanomaterials (Basel, Switzerland)2021
Fabrication of Silver-Decorated Graphene Oxide Nanohybrids via Pulsed Laser Ablation with Excellent Antimicrobial and Optical Limiting Performance.
Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 46 citations in OpenAlex.
- Progress in the application of graphene-based nanomaterials for gas adsorption and mitigation of air pollution.RSC advances · 2025Review
- Microwave-assisted graphene oxide/carbon spheres with silver nanoparticles: dual catalyst for peroxide detection and antibacterial use.Royal Society open science · 2025Article
- Investigations on the Nonlinear Optical Properties of 0D, 1D, and 2D Boron Nitride Nanomaterials in the Visible Spectral Region.Nanomaterials (Basel, Switzerland) · 2023Article
- Fluorescence and Nonlinear Optical Response of Graphene Quantum Dots Produced by Pulsed Laser Irradiation in Toluene.Molecules (Basel, Switzerland) · 2022Article
- Synthesis of Graphene-Based Nanocomposites for Environmental Remediation Applications: A Review.Molecules (Basel, Switzerland) · 2022Review
- Surface-Enhanced Raman Sensing of Semi-Volatile Organic Compounds by Plasmonic Nanostructures.Nanomaterials (Basel, Switzerland) · 2021Review
- A detection method of Escherichia coli O157:H7 based on immunomagnetic separation and aptamers-gold nanoparticle probe quenching Rhodamine B's fluorescence: Escherichia coli O157:H7 detection method based on IMS and Apt-AuNPs probe quenching Rho B' s fluorescence.Food science and biotechnology · 2021Article
- An Overview of Functionalized Graphene Nanomaterials for Advanced Applications.Nanomaterials (Basel, Switzerland) · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The demand for metallic nanoparticle ornamented nanohybrid materials of graphene oxide (GO) finds copious recognition by virtue of its advanced high-tech applications. Far apart from the long-established synthesis protocols, a novel laser-induced generation of silver nanoparticles (Ag NPs) that are anchored onto the GO layers by a single-step green method named pulsed laser ablation has been exemplified in this work. The second and third harmonic wavelengths (532 nm and 355 nm) of an Nd:YAG pulsed laser is used for the production of Ag NPs from a bulk solid silver target ablated in an aqueous solution of GO to fabricate colloidal Ag-GO nanohybrid materials. UV-Vis absorption spectroscopy, Raman spectroscopy, and TEM validate the optical, structural, and morphological features of the hybrid nanomaterials. The results revealed that the laser-assisted in-situ deposition of Ag NPs on the few-layered GO surface improved its antibacterial properties, in which the hybrid nanostructure synthesized at a longer wavelength exhibited higher antibacterial action resistance to
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.